Acupuncture Therapy Based on Biological Specificity of Acupoints for Major Depressive Disorder
Status:
Not yet recruiting
Trial end date:
2025-12-30
Target enrollment:
Participant gender:
Summary
Acupoints are the stimulus points and reactive points for acupuncture to treat the diseases.
Therefore, this study is designed to detect the biological specificity of acupoints in
healthy participants and major depressive disorder (MDD) participants by using multiple
objective assessment tools. And then acupoints that are statistically different between the
two groups will be defined as strong reaction points, and other acupoints without
statistically different will be defined as weak response points. In addition, this clinical
trial will be conducted to explore whether the efficacy of stimulating strong reaction
acupoints is more effective than weak reaction points, thereby confirming the specificity of
the acupoint.
Phase:
N/A
Details
Lead Sponsor:
The Third Affiliated hospital of Zhejiang Chinese Medical University
Collaborators:
The Affiliated Hangzhou First People's Hospital The Zhejiang Provincial Tongde Hospital